References
- Zong M, Lundberg IE. Pathogenesis, classification and treatment of inflammatory myopathies. Nat Rev Rheumatol 2011;7:297–306.
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344–347.
- Yen TH, Lai PC, Chen CC, Hsueh S, Huang JY. Renal involvement in patients with polymyositis and dermatomyositis. Int J Clin Pract 2005;59:188–193.
- Tournadre A, Amarger S, Joly P, d’Incan M, Ristori JM, Soubrier M. Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab. Joint Bone Spine 2008;75:728–729.
- Toledo K, Pérez MJ, Espinosa M, Ortega R, Aljama P. Antisynthetase syndrome without myositis secondary to AA amyloidosis: a non-described association. Nefrologia 2011;31:117–119.
- Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649–655.
- Koivuniemi R, Paimela L, Suomalainen R, Tornroth T, Leirisalo-Repo M. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008;15:262–268.
- De Paepe B, Creus KK, Martin JJ, Weis J, De Bleecker JL. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. Ann N Y Acad Sci 2009;1173:463–469.
- van der Hilst JC. Recent insights into the pathogenesis of type AA amyloidosis. ScientificWorldJournal 2011;11:641–650.